- $615.59m
- $568.86m
- $218.02m
- 65
- 21
- 98
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 70.6 | 93.5 | 138 | 193 | 218 |
Cost of Revenue | |||||
Gross Profit | 50.1 | 72.1 | 106 | 140 | 171 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 86.7 | 113 | 204 | 281 | 247 |
Operating Profit | -16.1 | -19.7 | -66.1 | -87.9 | -28.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -17.2 | -21.4 | -68 | -83.1 | -27.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.7 | -22 | -69 | -83.7 | -29.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -17.7 | -22 | -69 | -83.7 | -29.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -17.7 | -22.8 | -69 | -83.7 | -29.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.238 | -0.307 | -1.26 | -1.08 | -0.369 |
Dividends per Share |